Synthesis, characterization and biological activities of Ni(II), Cu(II) and UO 2 (VI) complexes of N'-((2Z,3E)-3-(hydroxyimino)butan-2-ylidene)-2-phenylacetohydrazide
Journal of Molecular Structure, ISSN: 0022-2860, Vol: 1175, Page: 39-48
2019
- 20Citations
- 24Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
In this study, the mononuclear Ni(II), Cu(II) and UO 2 (VI) complexes of N'-((2Z,3E)-3-(hydroxyimino)butan-2-ylidene)-2-phenylacetohydrazide ligand (LH 2 ) have been synthesized. All compounds have been characterized by using elemental, spectral, X-ray analyses and magnetic moment measurements. The IR spectra of Ni(II) and UO 2 (VI) complexes show that LH 2 has coordinated to the metal ions in tridentate manner with ON 2 donor sites of deprotonated phenolic OH, the imine N atoms of hydrazone (CO N) and oxime (C N OH) groups. In the Cu(II) complex, the ligand is ketoamine form and bond to metal ion via carbonyl oxygen, imine nitrogen atoms of oxime and hydrazone groups. The spectral and magnetic studies show that the Ni(II), and Cu(II) complexes exhibit octahedral geometry. UO 2 (VI) complex has a monomeric structure constructed of a hexagonal bipyramidal uranyl centre with two monodentate ligand in trans-position. Newly complexes have been tested for antimicrobial and antioxidant activity. All of the complexes have active against L. monocytogenes, M. luteus, S. epidermis, B. cereus, S. typhi H, E. coli, Klebsiella pneumonia, Br. abortus and C. albicans. Results of antioxidant activities indicate that the ligand and complexes have multiple antioxidant activities, such as total antioxidant (phosphomolybdenum) assay, reducing power, free radical (DPPH ), superoxide anion and ABTS + scavenging activity tests. The Ni(II) complex exhibited more effective total antioxidant activity and reducing power than BHA and trolox but weak the ABTS ·+, free radical (DPPH • ), and superoxide anion (O 2 ·- ) scavenging activity. The ABTS ·+ and DPPH • scavenging activities of Cu(II) were found excellent in comparison with standards. Ni(II), and UO 2 (VI) acted a powerful inhibitor of superoxide anion. The Cu(II) complex crystallized in the monoclinic space group C 2/ c, while UO 2 (VI) complex crystallized in the monoclinic space group P21/c.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0022286018308792; http://dx.doi.org/10.1016/j.molstruc.2018.07.060; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85053118560&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S0022286018308792; https://dul.usage.elsevier.com/doi/; https://api.elsevier.com/content/article/PII:S0022286018308792?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0022286018308792?httpAccept=text/plain; https://dx.doi.org/10.1016/j.molstruc.2018.07.060
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know